News Breathing space for GSK as Mylan's Advair copy rejected Stay of execution for ageing blockbuster
News Mylan recalls 81,000 EpiPens after reports of failures Recall follows two reports that allergy injection device failed.
News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News Use generic alternatives to Seretide and save millions, advi... Earlier use of montelukast could save NHS millions, says NICE.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
